$147 Million is the total value of Birchview Capital, LP's 64 reported holdings in Q3 2021. The portfolio turnover from Q2 2021 to Q3 2021 was 12.9% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| BMY | BRISTOL-MYERS SQUIBB CO | $47,106,000 | -11.4% | 796,106 | 0.0% | 32.05% | +0.7% | |
| AXDX | Buy | ACCELERATE DIAGNOSTICS INC | $13,096,000 | -27.1% | 2,252,388 | +0.9% | 8.91% | -17.0% |
| BDSX | BIODESIX INC | $9,083,000 | -37.8% | 1,104,953 | 0.0% | 6.18% | -29.2% | |
| QDEL | QUIDEL CORP | $8,424,000 | +10.2% | 59,684 | 0.0% | 5.73% | +25.3% | |
| NBIX | NEUROCRINE BIOSCIENCES INC | $7,692,000 | -1.4% | 80,200 | 0.0% | 5.23% | +12.1% | |
| FHTX | FOGHORN THERAPEUTICS INC | $4,376,000 | +30.5% | 314,143 | 0.0% | 2.98% | +48.5% | |
| BIIB | Buy | BIOGEN INC | $3,566,000 | -14.9% | 12,600 | +4.1% | 2.43% | -3.2% |
| ALBO | Buy | ALBIREO PHARMA INC | $3,526,000 | -9.7% | 113,000 | +1.8% | 2.40% | +2.7% |
| UTHR | UNITED THERAPEUTICS CORP | $3,322,000 | +2.9% | 18,000 | 0.0% | 2.26% | +17.1% | |
| ACAD | ACADIA PHARMACEUTICALS INC | $3,312,000 | -31.9% | 199,400 | 0.0% | 2.25% | -22.5% | |
| PRTA | Buy | PROTHENA CORP PLC | $2,867,000 | +84.4% | 40,247 | +33.1% | 1.95% | +109.8% |
| MASI | MASIMO CORP | $2,166,000 | +11.6% | 8,000 | 0.0% | 1.47% | +27.1% | |
| XLRN | Sell | ACCELERON PHARMA INC | $1,837,000 | -21.6% | 10,672 | -42.8% | 1.25% | -10.8% |
| CLR | CONTINENTAL RESOURCES INC | $1,781,000 | +21.3% | 38,600 | 0.0% | 1.21% | +38.0% | |
| HROW | HARROW HEALTH INC | $1,636,000 | -2.2% | 180,000 | 0.0% | 1.11% | +11.3% | |
| BLUE | Buy | BLUEBIRD BIO INC | $1,605,000 | -32.2% | 84,000 | +13.5% | 1.09% | -22.9% |
| ALKS | ALKERMES PLC | $1,542,000 | +25.8% | 50,000 | 0.0% | 1.05% | +43.1% | |
| AMRN | AMARIN CORP PLCspons adr new | $1,530,000 | +16.4% | 300,000 | 0.0% | 1.04% | +32.4% | |
| KPTI | Buy | KARYOPHARM THERAPEUTICS INC | $1,432,000 | -39.7% | 246,000 | +7.0% | 0.97% | -31.4% |
| BHVN | BIOHAVEN PHARMACEUTICAL HOLDING CO LTD | $1,389,000 | +43.0% | 10,000 | 0.0% | 0.94% | +62.7% | |
| VNDA | VANDA PHARMACEUTICALS INC | $1,371,000 | -20.3% | 80,000 | 0.0% | 0.93% | -9.3% | |
| ETRN | EQUITRANS MIDSTREAM CORPORATIO | $1,349,000 | +19.2% | 133,050 | 0.0% | 0.92% | +35.6% | |
| ARNA | ARENA PHARMACEUTICALS INC | $1,310,000 | -12.7% | 22,000 | 0.0% | 0.89% | -0.7% | |
| NKTR | NEKTAR THERAPEUTICS | $1,293,000 | +4.6% | 72,000 | 0.0% | 0.88% | +19.1% | |
| ARVN | ARVINAS INC | $1,233,000 | +6.8% | 15,000 | 0.0% | 0.84% | +21.4% | |
| OVV | OVINTIV INC | $1,124,000 | +4.5% | 34,200 | 0.0% | 0.76% | +18.8% | |
| IMGN | IMMUNOGEN INC | $1,077,000 | -14.0% | 190,000 | 0.0% | 0.73% | -2.1% | |
| CGEM | CULLINAN ONCOLOGY INC | $1,018,000 | -12.4% | 45,114 | 0.0% | 0.69% | -0.3% | |
| CORT | CORCEPT THERAPEUTICS INC | $984,000 | -10.5% | 50,000 | 0.0% | 0.67% | +1.8% | |
| CYTK | Buy | CYTOKINETICS INC | $894,000 | +351.5% | 25,000 | +150.0% | 0.61% | +415.3% |
| PGNY | PROGYNY INC | $840,000 | -5.1% | 15,000 | 0.0% | 0.57% | +8.1% | |
| SLNO | SOLENO THERAPEUTICS INC | $811,000 | -18.9% | 876,899 | 0.0% | 0.55% | -7.7% | |
| CFRX | CONTRAFECT CORP | $810,000 | -8.0% | 200,000 | 0.0% | 0.55% | +4.8% | |
| KALV | KALVISTA PHARMACEUTICALS INC | $698,000 | -27.1% | 40,000 | 0.0% | 0.48% | -17.1% | |
| PTGX | Buy | PROTAGONIST THERAPEUTICS INC | $673,000 | +49.9% | 38,000 | +280.0% | 0.46% | +70.3% |
| PXD | PIONEER NATURAL RESOURCES CO | $633,000 | +2.4% | 3,800 | 0.0% | 0.43% | +16.5% | |
| NARI | INARI MEDICAL INC | $568,000 | -13.0% | 7,000 | 0.0% | 0.39% | -1.0% | |
| GTHX | G1 THERAPEUTICS INC | $537,000 | -38.8% | 40,000 | 0.0% | 0.36% | -30.5% | |
| ZNTL | ZENTALIS PHARMACEUTICALS INC | $533,000 | +25.1% | 8,000 | 0.0% | 0.36% | +42.4% | |
| ANGN | Sell | ANGION BIOMEDICA CORP | $531,000 | -72.6% | 54,392 | -10.3% | 0.36% | -68.9% |
| TPTX | TURNING POINT THERAPEUTICS INC | $531,000 | -14.9% | 8,000 | 0.0% | 0.36% | -3.2% | |
| GOSS | New | GOSSAMER BIO INC | $503,000 | – | 40,000 | +100.0% | 0.34% | – |
| TGTX | TG THERAPEUTICS INC | $499,000 | -14.3% | 15,000 | 0.0% | 0.34% | -2.3% | |
| CCXI | Sell | CHEMOCENTRYX INC | $428,000 | +6.5% | 25,000 | -16.7% | 0.29% | +21.2% |
| PROG | PROGENITY INC | $410,000 | -57.5% | 270,000 | 0.0% | 0.28% | -51.6% | |
| XNCR | XENCOR INC | $402,000 | -5.2% | 12,300 | 0.0% | 0.27% | +7.9% | |
| APLS | Buy | APELLIS PHARMACEUTICALS INC | $396,000 | -21.7% | 12,000 | +50.0% | 0.27% | -11.2% |
| STOK | STOKE THERAPEUTICS INC | $382,000 | -24.4% | 15,000 | 0.0% | 0.26% | -13.9% | |
| FOLD | AMICUS THERAPEUTICS INC | $363,000 | -0.8% | 38,000 | 0.0% | 0.25% | +12.8% | |
| AZYO | Buy | AZIYO BIOLOGICS INC | $348,000 | +20.8% | 50,000 | +66.7% | 0.24% | +37.8% |
| KNSA | Buy | KINIKSA PHARMACEUTICALS LTD | $342,000 | +22.6% | 30,000 | +50.0% | 0.23% | +39.5% |
| AWH | ASPIRA WOMENS HEALTH INC | $335,000 | -42.1% | 103,104 | 0.0% | 0.23% | -34.1% | |
| AKBA | AKEBIA THERAPEUTICS INC | $288,000 | -24.0% | 100,000 | 0.0% | 0.20% | -13.7% | |
| BCRX | BIOCRYST PHARMACEUTICALS INC | $287,000 | -9.2% | 20,000 | 0.0% | 0.20% | +3.2% | |
| LSF | LAIRD SUPERFOOD INC | $267,000 | -36.1% | 14,000 | 0.0% | 0.18% | -27.2% | |
| AVEO | New | AVEO PHARMACEUTICALS INC | $247,000 | – | 40,000 | +100.0% | 0.17% | – |
| ISEE | New | IVERIC BIO INC | $244,000 | – | 15,000 | +100.0% | 0.17% | – |
| IRTC | New | IRHYTHM TECHNOLOGIES INC | $234,000 | – | 4,000 | +100.0% | 0.16% | – |
| SIEN | SIENTRA INC | $229,000 | -28.0% | 40,000 | 0.0% | 0.16% | -17.9% | |
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | $215,000 | -12.6% | 9,000 | 0.0% | 0.15% | -0.7% | |
| IFRX | INFLARX NV | $181,000 | -13.0% | 70,000 | 0.0% | 0.12% | -0.8% | |
| YTEN | New | YIELD10 BIOSCIENCE INC | $113,000 | – | 18,785 | +100.0% | 0.08% | – |
| TXMD | THERAPEUTICSMD INC | $74,000 | -37.8% | 100,000 | 0.0% | 0.05% | -29.6% | |
| CNCE | CONCERT PHARMACEUTICALS INC | $65,000 | -22.6% | 20,000 | 0.0% | 0.04% | -12.0% | |
| HOOK | Exit | HOOKIPA PHARMA INC | $0 | – | -20,000 | -100.0% | -0.11% | – |
| DRNA | Exit | DICERNA PHARMACEUTICALS INC | $0 | – | -10,000 | -100.0% | -0.22% | – |
| TBIO | Exit | TRANSLATE BIO INC | $0 | – | -30,000 | -100.0% | -0.49% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-11-12
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ACCELERATE DIAGNOSTICS INC | 36 | Q3 2023 | 34.6% |
| QUIDELORTHO CORP | 36 | Q3 2023 | 8.6% |
| MASIMO CORP | 36 | Q3 2023 | 2.2% |
| PIONEER NATURAL RESOURCES CO (PXD) | 36 | Q3 2023 | 0.7% |
| XENCOR INC | 35 | Q3 2023 | 0.4% |
| NEUROCRINE BIOSCIENCES INC | 33 | Q3 2023 | 7.4% |
| CORCEPT THERAPEUTICS INC | 32 | Q3 2023 | 1.2% |
| BIOGEN INC | 31 | Q2 2022 | 3.1% |
| CONTRAFECT CORP | 30 | Q3 2022 | 1.6% |
| YIELD10 BIOSCIENCE INC | 26 | Q3 2023 | 0.6% |
View Birchview Capital, LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| SOLENO THERAPEUTICS INC | March 19, 2019 | 742,635 | 2.3% |
| YIELD10 BIOSCIENCE, INC. | December 29, 2017 | 186,079 | 2.2% |
| HANSEN MEDICAL INC | February 16, 2016 | ? | ? |
| METABOLIX, INC. | June 23, 2015 | 749,696 | 2.8% |
View Birchview Capital, LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 3/A | 2024-02-20 |
| 4/A | 2024-02-20 |
| SC 13G/A | 2024-02-20 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-08 |
| 13F-HR | 2023-05-12 |
| SC 13G/A | 2023-04-07 |
| 4 | 2023-03-27 |
| 3 | 2023-02-13 |
View Birchview Capital, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.